Mario Gaio
Naples, 80138, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Semaglutide Exposure During Pregnancy: Results from the FAERS Database.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 03, 2026
Unmasking counterfeit semaglutide: analysis of real-world safety data from EudraVigilance.
Journal: Frontiers in pharmacology
Published: February 06, 2026
Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022-2024).
Journal: Pharmacological reports : PR
Published: December 29, 2025
Safety profile of FLT3 inhibitors in acute myeloid leukemia: a systematic review and meta-analysis of adverse events.
Journal: Clinical and experimental medicine
Published: November 21, 2025
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination.
Journal: Scientific reports
Published: December 18, 2024
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database.
Journal: Pharmacological reports : PR
Published: June 17, 2024
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 20, 2024
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021).
Journal: Oral diseases
Published: April 16, 2024
The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database.
Journal: Biomedicines
Published: August 28, 2023
Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 20, 2023
A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database.
Journal: Biomedicines
Published: July 06, 2023
Last Updated: 09/26/2026